This is a non-core endpoint: only basic statistics are computed.
Traumatic amputation of ankle and foot
ST19_TRAUMAT_AMPUT_ANKLE_FOOT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
88 |
4. Check minimum number of eventsNone |
88 |
5. Include endpointsNone |
88 |
6. Filter based on genotype QC (FinnGen only) |
88 |
Control definitions (FinnGen only)
- Control exclude
- ST19_INJURI_ANKLE_FOOT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S90
- Name in latin
- Amputatio traumatica tarsi/pedis
Similar endpoints
↥List of similar endpoints to
Traumatic amputation of ankle and foot
based on the number of shared cases.
Similar with more cases:
- Injuries to the ankle and foot
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 88 | 22 | 66 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 54.68 | 54.25 | 54.82 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 81
- Matched controls
- 811
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S98.1
ICD-10 Finland
Traumatic amputation of one toe
+∞
57.2
48
*
S98.2
ICD-10 Finland
Traumatic amputation of two or more toes
+∞
24.2
22
*
NHQ40
NOMESCO Finland
Amputation of toe
41.7
19.7
24
8
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
39.4
18.7
23
8
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
52.2
17.3
20
5
W31
ICD-10 Finland
Contact with other and unspecified machinery
15.0
10.4
17
14
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
62.8
9.9
11
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
34.7
9.7
12
*
A46
ICD-10 Finland
Erysipelas
7.1
9.7
25
48
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
56.3
8.9
10
*
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
+∞
8.5
8
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
6.0
8.3
24
53
S92.5
ICD-10 Finland
Fracture of other toe
37.5
8.3
10
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
9.0
8.2
17
23
NHQ48
NOMESCO Finland
Revision of amputation of toe
+∞
7.4
7
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
6.0
6.9
19
39
S98.4
ICD-10 Finland
Traumatic amputation of foot, level unspecified
+∞
6.3
6
*
NGQ20
NOMESCO Finland
Amputation of lower leg
+∞
6.3
6
*
ZZA00
NOMESCO Finland
Split skin graft
14.0
6.3
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
23
75
3.80
6.33
3.3
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
40
209
2.68
4.79
3.0
3.0
mmol/l
7.1
8.3
1.03
33
178
(3042936) Bacteria identified in Isolate by Culture
23
89
3.14
4.78
3.7
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
7
10.72
4.08
1.0
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
37
212
2.29
3.41
3.8
3.7
mg/mmol
13.8
10.9
0.16
21
139
(3012516) Albumin [Mass/volume] in Urine
34
194
2.23
3.12
3.0
3.1
mg/l
108.3
432.4
0.45
21
129
(3000093) Morphology [Interpretation] in Blood Narrative
5
6
8.73
2.78
1.0
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
15
4.97
2.65
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
31
195
1.91
2.07
2.8
3.2
ng/l
2595.0
1104.9
0.39
25
169
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
21
3.53
2.01
1.3
2.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
42
295
1.81
1.97
12.1
7.4
inr
1.3
1.2
0.11
12
81
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
11
4.75
1.97
1.2
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
22
3.36
1.92
1.1
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
29
185
1.85
1.83
6.8
4.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
31
2.73
1.70
1.6
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
38
279
1.64
1.41
3.7
3.7
ng/l
53.1
46.5
0.08
32
192
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
23
2.72
1.39
1.8
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
34
2.48
1.33
1.8
1.5
—
—
—
0
0
(4034850)
6
24
2.61
1.33
12.2
17.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
35
2.41
1.31
1.8
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
35
2.41
1.31
1.8
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
18
110
1.80
1.28
1.7
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
19
2.73
1.23
1.4
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
10
50
2.13
1.22
1.3
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
56
645
0.64
1.15
24.8
13.9
%
42.0
40.8
0.66
35
493
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
31
226
1.57
1.15
2.7
2.4
u/l
49.2
53.9
0.54
31
216
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
16
98
1.77
1.13
2.3
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
33
2.22
1.08
2.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
35
2.08
1.02
1.6
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
41
325
1.49
1.02
8.5
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
50
1.89
1.00
1.3
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
30
224
1.51
0.99
8.0
2.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
17
243
0.63
0.91
1.6
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
35
274
1.46
0.91
3.4
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
56
483
1.44
0.84
3.7
3.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
32
1.94
0.83
4.7
7.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
50
424
1.42
0.82
2.7
3.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
25
0.00
0.80
0.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
11
67
1.73
0.79
4.0
2.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
30
236
1.41
0.74
2.1
2.2
nmol/l
66.0
71.2
0.51
25
207
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
41
1.77
0.72
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
26
1.98
0.72
4.2
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
43
1.68
0.68
1.4
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
21
159
1.42
0.63
2.7
2.3
—
—
—
0
0
(3013512) EKG study
23
178
1.40
0.61
4.7
4.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
21
0.00
0.61
0.0
2.3
—
69.6
—
0
21
(40768797) Stomach Pathology biopsy report
13
90
1.52
0.59
1.3
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
23
0.00
0.59
0.0
1.7
—
4.4
—
0
18
(40768800) Prostate Pathology biopsy report
0
23
0.00
0.59
0.0
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
28
226
1.35
0.58
7.2
5.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
6
36
1.71
0.58
5.0
2.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
36
1.71
0.58
1.5
2.8
—
—
—
0
0
(3012544) pH of Venous blood
9
61
1.53
0.56
3.9
3.4
—
—
—
0
0
(3015736) pH of Urine
31
256
1.33
0.55
3.2
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
21
164
1.37
0.53
4.8
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
18
229
0.73
0.51
1.4
2.9
ug/l
0.5
0.7
—
5
149
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
85
1.48
0.50
2.4
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
23
281
0.75
0.50
3.3
2.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
7
46
1.57
0.50
5.3
1.8
e9/l
81.4
78.1
—
7
37
(3009261) Glucose [Presence] in Urine by Test strip
40
348
1.27
0.48
3.4
3.4
estimate
0.0
0.0
—
6
60
(40761535) Cells panel - Urine sediment
7
49
1.46
0.47
2.7
3.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
51
460
1.26
0.44
4.2
3.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
29
245
1.27
0.43
1.6
1.9
pmol/l
85.6
90.7
—
10
112
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
32
1.60
0.43
2.2
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
12
88
1.42
0.42
1.2
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
16
124
1.35
0.42
1.1
1.3
g/l
3.3
2.6
—
8
85
(3000991) Gas panel - Venous blood
8
59
1.39
0.42
6.6
9.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
15
115
1.37
0.42
2.6
1.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.3
—
620.9
—
0
16
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
71
670
1.31
0.39
4.6
4.4
mmol/l
6.2
6.1
0.52
63
620
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
36
1.41
0.39
1.0
2.7
g/l
122.0
131.4
—
5
36
(3035350) Ketones [Presence] in Urine by Test strip
38
338
1.22
0.35
3.6
3.4
estimate
0.0
0.0
—
6
62
(3014007) Fractional oxyhemoglobin in Arterial blood
6
44
1.39
0.35
3.7
11.6
%
94.7
94.4
—
6
44
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
69
652
1.27
0.35
7.4
5.4
mmol/mol
41.3
40.4
0.26
64
617
(3022145) Colonoscopy Study observation
6
87
0.67
0.35
1.2
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
147
1.28
0.34
3.0
3.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
6
46
1.33
0.34
1.7
3.2
g/l
64.0
67.6
—
6
41
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
52
479
1.21
0.33
4.8
3.1
u/l
62.4
52.2
0.28
52
456
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
56
1.27
0.30
2.3
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
13
104
1.29
0.28
3.2
3.3
mmol/l
2.4
2.4
—
7
90
(3020564) Creatinine [Moles/volume] in Serum or Plasma
78
754
1.30
0.26
23.0
15.5
umol/l
87.7
82.4
0.32
78
754
(3000494) Fungus identified in Specimen by Culture
9
76
1.20
0.25
1.6
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
5
39
1.30
0.23
8.2
4.7
mmol/l
23.0
24.8
—
5
39
(40761511) CBC panel - Blood by Automated count
76
735
1.25
0.23
22.6
12.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
59.9
—
0
10
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
6
47
1.30
0.21
2.5
3.2
—
60.4
—
0
23
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
48
1.27
0.21
1.0
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
37
341
1.15
0.20
4.6
4.5
estimate
0.0
0.0
—
7
66
(40768793) Breast Pathology biopsy report
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
2.9
—
135.0
—
0
9
(3019060) Gas panel - Arterial blood
6
51
1.19
0.20
2.3
4.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
10
81
1.26
0.20
2.0
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
72
696
1.19
0.19
25.0
13.1
mg/l
22.3
25.5
0.41
62
544
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
36
388
0.88
0.19
3.5
4.7
ug/l
1.7
1.9
0.21
31
345
(3003694) ABO and Rh group [Type] in Blood
21
186
1.17
0.19
1.3
1.4
—
—
—
0
0
(3019225) pH of Specimen
7
57
1.25
0.19
19.7
3.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
7
60
1.18
0.18
3.6
2.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
8
69
1.18
0.17
3.6
2.1
%
2.5
1.9
—
8
64
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
8
70
1.16
0.17
4.4
3.7
u/l
242.5
237.4
—
8
65
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
16
140
1.17
0.16
1.2
1.7
mg/l
1.7
1.2
0.24
11
119
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
77
1.19
0.16
12.7
8.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
27
248
1.13
0.15
3.8
2.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
17
189
0.88
0.13
4.6
2.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
23
250
0.89
0.13
4.6
3.3
e6/l
103.8
66.0
0.24
18
188
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
85
1.20
0.13
2.0
1.7
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
10
116
0.84
0.12
4.6
2.3
umol/l
11.5
14.0
—
10
108
(3019309) Folate [Moles/volume] in Red Blood Cells
13
115
1.15
0.11
2.0
1.6
nmol/l
1979.6
1203.2
—
8
91
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
13
116
1.14
0.10
3.2
2.4
e6/l
1.2
1.3
—
8
65
(40761536) Microorganisms panel - Urine sediment
6
54
1.12
0.09
2.5
4.3
—
—
—
0
0
(4010399)
6
54
1.12
0.09
1.5
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
10
113
0.87
0.09
3.5
2.4
e6/l
1.1
1.0
—
5
65
(3002256) Pathology report gross observation
6
70
0.85
0.08
1.2
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
72
732
0.91
0.07
27.3
14.8
mmol/l
4.0
4.0
0.66
72
710
(3019550) Sodium [Moles/volume] in Serum or Plasma
72
729
0.93
0.03
27.1
14.7
mmol/l
139.2
139.7
0.98
72
710
(3041096) Erythrocytes [Presence] in Urine by Automated
22
211
1.06
0.03
3.1
3.0
—
—
—
0
0
(3026782) Osmolality of Urine
13
138
0.93
0.02
3.7
2.7
mosm/kgh2o
422.0
594.4
—
8
123
(40758558) Short blood count panel - Blood
19
182
1.06
0.02
6.2
6.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
20
192
1.05
0.02
4.1
2.8
e6/l
0.3
0.4
0.52
14
145
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
66
652
1.05
0.02
17.8
12.5
ml/min/173m2
80.3
82.9
0.36
59
541
(3029937) Albumin [Presence] in Urine by Test strip
19
183
1.05
0.01
3.9
3.6
estimate
0.0
0.0
—
6
60
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14
134
1.05
0.00
2.3
1.9
pmol/l
481.6
428.6
0.24
14
119
(40760892) CBC W Ordered Manual Differential panel - Blood
15
153
0.98
0.00
12.5
4.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
30
303
0.98
0.00
3.6
4.4
%
24.8
20.8
—
10
142
(3002582) Erythrocytes [#/volume] in Urine
22
221
0.99
0.00
4.0
2.9
e6/l
19.4
317.6
0.53
17
174
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
49
1.02
0.00
2.2
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
79
790
1.00
0.00
33.8
19.2
fl
91.6
90.9
0.65
79
779
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
8
0.00
0.00
0.0
5.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.1
—
100.9
—
0
8
(3011985) Renin [Units/volume] in Plasma
0
5
0.00
0.00
0.0
1.2
—
21.4
—
0
5
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
263.3
—
0
6
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
79
791
0.99
0.00
33.8
19.2
pg
30.4
30.4
0.03
79
780
(21494755) Public health laboratory ask at order entry panel
8
88
0.90
0.00
1.4
1.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
79
791
0.99
0.00
34.0
19.3
e12/l
4.4
4.6
1.44
79
769
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000492) Spirometry study
7
73
0.96
0.00
1.3
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.7
—
4.1
—
0
7
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
79
791
0.99
0.00
34.1
19.4
e9/l
7.0
6.7
0.80
79
771
(3035285) Chloride [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
2.7
—
107.6
—
0
7
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.2
—
10.5
—
0
5
(3045424) Erythrocytes [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
3.9
—
179.1
—
0
9
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
59
1.02
0.00
2.0
1.7
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
0.00
0.0
3.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
16.2
—
0
5
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.6
—
52.0
—
0
5
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
79
791
0.99
0.00
34.0
19.3
e9/l
250.1
241.0
0.59
79
772
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4268621)
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
79
791
0.99
0.00
34.5
19.4
g/l
134.3
139.3
1.58
79
779
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
3.7
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
0.8
—
0
5
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
353.8
—
0
6
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
6.0
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_TRAUMAT_AMPUT_ANKLE_FOOT – Traumatic amputation of ankle and foot
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).